BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15143931)

  • 1. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.
    Katz MH; Bouvet M; Al-Refaie W; Gilpin EA; Moossa AR
    Hepatogastroenterology; 2004; 51(57):842-6. PubMed ID: 15143931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
    Schwarz RE; Keny H
    Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
    Sellner FJ; Riegler FM; Machacek E
    Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.
    van Roest MH; Gouw AS; Peeters PM; Porte RJ; Slooff MJ; Fidler V; de Jong KP
    Ann Surg; 2008 Jul; 248(1):97-103. PubMed ID: 18580212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of outcomes of a series of periampullary carcinomas.
    Berberat PO; Künzli BM; Gulbinas A; Ramanauskas T; Kleeff J; Müller MW; Wagner M; Friess H; Büchler MW
    Eur J Surg Oncol; 2009 Feb; 35(2):187-91. PubMed ID: 18343082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
    Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
    Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does lymph node ratio impact survival in resected periampullary malignancies?
    Hurtuk MG; Hughes C; Shoup M; Aranha GV
    Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological characteristics of surgical effect on periampullary cancers: report of 631 cases].
    Shao YF; Wu TC; Shan Y; Wu JX; Wang X; Zhao P
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):510-3. PubMed ID: 15949327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
    Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
    Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of surgical treatment of periampullary tumors: a thirty-five-year experience.
    Tarazi RY; Hermann RE; Vogt DP; Hoerr SO; Esselstyn CB; Cooperman AM; Steiger E; Grundfest S
    Surgery; 1986 Oct; 100(4):716-23. PubMed ID: 3764694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic and periampullary tumors: morbidity, mortality, functional results and long-term survival].
    Sabater L; Calvete J; Aparisi L; Cánovas R; Muñoz E; Añón R; Roselló S; Rodríguez E; Camps B; Alfonso R; Sala C; Sastre J; Cervantes A; Lledó S
    Cir Esp; 2009 Sep; 86(3):159-66. PubMed ID: 19616203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreaticoduodenal resection for pancreatic or periampullary tumors--a ten-year experience.
    Ceuterick M; Gelin M; Rickaert F; Van de Stadt J; Devière J; Cremer M; Lambilliotte JP
    Hepatogastroenterology; 1989 Dec; 36(6):467-73. PubMed ID: 2613168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of surgical treatment of Vater's ampulla neoplasms.
    Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
    Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histopathologic type of the periampullary tumors. Is it important for survival?
    Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
    Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.